These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10102941)

  • 21. Pathology of deaths associated with "ecstasy" and "eve" misuse.
    Milroy CM; Clark JC; Forrest AR
    J Clin Pathol; 1996 Feb; 49(2):149-53. PubMed ID: 8655682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ecstasy: a common cause of severe acute hepatotoxicity.
    Andreu V; Mas A; Bruguera M; Salmerón JM; Moreno V; Nogué S; Rodés J
    J Hepatol; 1998 Sep; 29(3):394-7. PubMed ID: 9764985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acute hepatitis due to ecstasy].
    Roques V; Perney P; Beaufort P; Hanslik B; Ramos J; Durand L; Le Bricquir Y; Blanc F
    Presse Med; 1998 Mar; 27(10):468-70. PubMed ID: 9767974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acute hepatitis due to ingestion of Ecstasy].
    Huarte Muniesa MP; Pueyo Royo AM
    Rev Esp Enferm Dig; 1995 Sep; 87(9):681-3. PubMed ID: 7577130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ecstasy].
    Trkulja V; Lacković Z
    Lijec Vjesn; 1997; 119(5-6):158-66. PubMed ID: 9379824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ecstasy--the status in French-speaking Switzerland. Composition of seized drugs, analysis of biological specimens and short review of its pharmacological action and toxicity].
    Giroud C; Augsburger M; Sadeghipour F; Varesio E; Veuthey JL; Rivier L
    Praxis (Bern 1994); 1997 Mar; 86(13):510-23. PubMed ID: 9157497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Poisoning with central nervous system stimulants. Amphetamine, ecstasy, cocaine and gamma-hydroxybutyrate].
    Christensen HR
    Ugeskr Laeger; 1999 Dec; 161(50):6899. PubMed ID: 10643372
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison and evaluation of DRI methamphetamine, DRI ecstasy, Abuscreen ONLINE amphetamine, and a modified Abuscreen ONLINE amphetamine screening immunoassays for the detection of amphetamine (AMP), methamphetamine (MTH), 3,4-methylenedioxyamphetamine (MDA), and 3,4-methylenedioxymethamphetamine (MDMA) in human urine.
    Stout PR; Klette KL; Wiegand R
    J Anal Toxicol; 2003; 27(5):265-9. PubMed ID: 12908938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of 3,4-methylenedioxymethamphetamine ("ecstasy") on body temperature and liver antioxidant status in mice: influence of ambient temperature.
    Carvalho M; Carvalho F; Remião F; de Lourdes Pereira M; Pires-das-Neves R; de Lourdes Bastos M
    Arch Toxicol; 2002 Apr; 76(3):166-72. PubMed ID: 11967622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver transplantation for ecstasy-induced fulminant hepatic failure.
    De Carlis L; De Gasperi A; Slim AO; Giacomoni A; Corti A; Mazza E; Di Benedetto F; Lauterio A; Arcieri K; Maione G; Rondinara GF; Forti D
    Transplant Proc; 2001 Aug; 33(5):2743-4. PubMed ID: 11498145
    [No Abstract]   [Full Text] [Related]  

  • 31. Three cases of fatal paramethoxyamphetamine overdose.
    Martin TL
    J Anal Toxicol; 2001 Oct; 25(7):649-51. PubMed ID: 11599618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rewarding effects of the optical isomers of 3,4-methylenedioxy-methylamphetamine ('Ecstasy') and 3,4-methylenedioxy-ethylamphetamine ('Eve') measured by conditioned place preference in rats.
    Meyer A; Mayerhofer A; Kovar KA; Schmidt WJ
    Neurosci Lett; 2002 Sep; 330(3):280-4. PubMed ID: 12270646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. False-positive amphetamine/ecstasy (MDMA/3,4-methylenedioxymethamphetamine) (CEDIA) and ecstasy (MDMA/3,4-methylenedioxymethamphetamine) (DRI) test results with fenofibrate.
    Kaplan YC; Erol A; Karadaş B
    Ther Drug Monit; 2012 Oct; 34(5):493-5. PubMed ID: 22972534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatality due to the use of a designer drug MDMA (Ecstasy).
    Kłys M; Rojek S; Woźniak K; Rzepecka-Woźniak E
    Leg Med (Tokyo); 2007 Jul; 9(4):185-91. PubMed ID: 17320458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ecstasy and related drugs in biological materials].
    Christophersen AS; Smith-Kielland A
    Tidsskr Nor Laegeforen; 1999 Feb; 119(5):702. PubMed ID: 10095396
    [No Abstract]   [Full Text] [Related]  

  • 36. [Mass spectrometry data of some metabolites of the amphetamine derivatives 3,4-(methylenedioxy) amphetamine (MDA) and 3,4-methylenedioxy)methylamphetamine (MDMA)].
    Verweij AM
    Arch Kriminol; 1996; 197(1-2):27-30. PubMed ID: 8851250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple toxicity from 3,4-methylenedioxymethamphetamine ("ecstasy").
    Greene SL; Dargan PI; O'connor N; Jones AL; Kerins M
    Am J Emerg Med; 2003 Mar; 21(2):121-4. PubMed ID: 12671812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A fatal case of myocardial damage due to misuse of the "designer drug" MDMA.
    Sano R; Hasuike T; Nakano M; Kominato Y; Itoh H
    Leg Med (Tokyo); 2009 Nov; 11(6):294-7. PubMed ID: 19828353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996-2002.
    Schifano F; Oyefeso A; Corkery J; Cobain K; Jambert-Gray R; Martinotti G; Ghodse AH
    Hum Psychopharmacol; 2003 Oct; 18(7):519-24. PubMed ID: 14533133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC
    J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.